SCHEMBL2887731

SCHEMBL2887731

CCOC(=O)c1c(C)c2ccccc2n1-c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.64
ALDH1A1 P00352 3/20 0.64
GAA P10253 2/20 0.64
RECQL P46063 1/20 0.61
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.51
THRB P10828 1/20 0.51
MAT2A P31153 1/20 0.50
ELANE P08246 1/20 0.50
ALOX15 P16050 1/20 0.49
MAPK8 P45983 1/20 0.48
KDM4E B2RXH2 3/20 0.47
HPGD P15428 2/20 0.47
PLA2G2A P14555 1/20 0.47
HSD17B10 Q99714 1/20 0.47
FOLH1 Q04609 1/20 0.47
TSHR P16473 1/20 0.47
TP53 P04637 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30639225 0.81 TSHR (0.66) MAPTALDH1A1GAAKMT2ASMN1; SMN2
SCHEMBL7878088 0.81 TSHR (0.66) MAPTALDH1A1GAAKMT2ASMN1; SMN2
SCHEMBL2885250 0.80 MEN1 (0.74) MAPTALDH1A1GAARECQLMEN1
SCHEMBL17456641 0.80 KDM4E (0.59) MAPTALDH1A1GAARECQLMEN1
SCHEMBL31070153 0.79 ELANE (0.49) MAPTALDH1A1GAARECQLMEN1
SCHEMBL12279719 0.79 HPGD (0.65) MAPTALDH1A1GAARECQLMEN1
SCHEMBL15005226 0.79 MAPT (1.00) MAPTALDH1A1GAARECQLMEN1
SCHEMBL31193397 0.78 MAPT (0.66) MAPTALDH1A1GAARECQLMEN1
SCHEMBL17625298 0.78 F10 (0.58) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL28819200 0.78 L3MBTL1 (0.54) MAPTALDH1A1GAARECQLMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124489-B1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2020-07-15 EP disclosed
EP-3124489-A1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS Fibrogen, Inc. (US) 2017-02-01 EP disclosed
EP-2016078-B1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2016-06-15 EP disclosed
US-7696223-B2 [(2-bromo-4-hydroxy-1-phenyl-1H-pyrrolo[2,3-c]pyridine-5-carbonyl)-amino]-acetic acid; modulates the stability and/or activity of hypoxia inducible factor (HIF) FIBROGEN, INC. (US) 2010-04-13 US disclosed
EP-2016078-A2 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN, INC. (US) 2009-01-21 EP disclosed
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF FIBROGEN, INC. 2008-01-03 US disclosed
WO-2007115315-A2 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN, INC. (US) 2007-10-11 WO disclosed
US-4272533-A ANTIDIABETIC, ANTIOBESITY SANDOZ LTD. (CH) 1981-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF HIF1AN, HIF1A, EGLN2 MAPT 2965/4885ALDH1A1 1047/4885GAA 2236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.